[1]
E. Kristin, “Medication Persistence to Lipid-lowering Agents As A Cost-saving Opportunities on Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention in Indonesia”, Indonesian J Pharm, vol. 33, no. 2, pp. 291–298, Apr. 2022.